You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Coming back: autophagy in cachexia

Penna, Fabio; Baccino, Francesco M.; Costelli, Paola

Current Opinion in Clinical Nutrition & Metabolic Care:
doi: 10.1097/MCO.0000000000000048
TRANSLATIONAL RESEARCH IN WASTING DISEASES: Edited by Vickie E. Baracos, Claude Pichard and Didier Attaix
Watch Video
Abstract

Purpose of review: Cachexia is a complex syndrome characterized by body weight loss, tissue wasting, systemic inflammation, metabolic abnormalities, and altered nutritional status. One of the most prominent features of cachexia is the loss of muscle mass, mainly because of increased protein degradation rates. This review is aimed at discussing the involvement of autophagy in the pathogenesis of muscle wasting in cachexia.

Recent findings: Modulations of muscle mass in the adult reflect an imbalance between protein synthesis and degradation rates. Muscle depletion in cachexia is associated with increased protein breakdown, mainly involving the pathways dependent on ubiquitin–proteasome and autophagy–lysosomes. This latter, in particular, was considered not relevant for a long time. Just in the last years, autophagy was shown to contribute to the pathogenesis of muscle wasting not only in myopathies because of intrinsic muscle defects, but also in muscle depletion associated with conditions such as sepsis, chronic obstructive pulmonary disease, glucocorticoid treatment, cancer cachexia, and aging.

Summary: The present review highlights that both excess and defective autophagy are relevant to the onset of muscle depletion, and draws some considerations about possible therapeutic intervention aimed at modulating autophagy in order to improve muscle trophism.

Video abstract: http://links.lww.com/COCN/A5.

Author Information

Unit of Experimental and Clinical Pathology, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy

Correspondence to Paola Costelli, Unit of Experimental and Clinical Pathology, Department of Clinical and Biological Sciences, University of Turin, Corso Raffaello 30, 10125, Turin, Italy. Tel: +39 11 6707062; fax: +39 11 6707753; e-mail: paola.costelli@unito.it

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.co-clinicalnutrition.com).

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins